Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleSHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms.AuthorsPandey, Garima; Mazzacurati, Lucia; Rowsell, Tegan M.; Horvat, Nathan P.; Amin, Narmin E.; Zhang, Guolin; Akuffo, Afua A.; Colin‐Leitzinger, Christelle M.; Haura, Eric B.; Kuykendall, Andrew T.; Zhang, Ling; Epling‐Burnette, Pearlie K.; Reuther, Gary W.PublicationAmerican Journal of Hematology, 2024, Vol 99, Issue 6, p1040ISSN0361-8609Publication typeArticleDOI10.1002/ajh.27282